NPPA allows price hike for coronary stents to reflect inflation, impacting heart patients' treatment costs in India.
The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for inflation.
NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...
Coronary artery bypass grafting is a more invasive procedure where surgeons use blood vessels from another part of the body ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
The global bioabsorbable stents market size was US$ 221.5 million in 2021. The global bioabsorbable stents market is forecast to grow to US$ 351.5 million by 2030 by growing at a compound annual ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
The Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceuticals (DoP) to review the pricing trends of critical medical devices including cardiac stents to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results